Navigation Links
Cylex(TM) Receives ISO 13485:2003 and 9001:2000 Quality Certifications
Date:9/30/2008

ISO certification confirms implementation of quality systems in product

design and development, manufacture, and distribution for Cylex's

ImmuKnow(R) immune cell function assay

COLUMBIA, Md., Oct. 1 /PRNewswire/ -- Cylex has announced receipt of certification to ISO 13485:2003 and 9001:2000. The 13485:2003 certification includes compliance with the Canadian Medical Devices Conformity Assessment System (CMDCAS). These certifications signify compliance with internationally recognized standards in design, development, and manufacturing of medical products. The certifications were issued by TUV Rheinland of North America.

"This is a major achievement for the Company," stated Brad L. Stewart, president of Cylex. "ISO certification confirms that quality systems have been implemented in product design and development, manufacture, operations, shipping, and service and will support CE marking of Cylex products that will be labeled for in vitro diagnostic use for sale within the European Community. In addition, the certification confirms that Cylex meets global quality design and manufacturing requirements for Canada."

ISO 13485:2003 provides Cylex's customers with a "Quality Pledge" in regard to the Company's ongoing dedication to quality manufacturing, as well as demonstrating our readiness to take on the demanding challenges of building medical devices that are robust and reliable.

"In addition to the ISO 13485:2003 certificate, Cylex voluntarily elected to obtain certification to ISO 9001:2000 as well," Stewart went on to say. "We did this to demonstrate our commitment to customer focus, customer satisfaction, and continuous quality improvement. And I want to take this opportunity to clearly recognize all Cylex's employees for the dedication, focus, and hard work that has made this certification possible."

Certification to ISO standards is a baseline quality system requirement in many key markets for app
'/>"/>

SOURCE Cylex
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
5. IsoTis Receives FDA Clearance for Accell Family of Products
6. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
7. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
8. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
9. XTL Receives Staff Letter From NASDAQ
10. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
11. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Charles Darwin: More than the origin 2Charles Darwin: More than the origin 3Oceans day at International Climate Change Conference 2Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 1Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 2Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 3Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 4Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 5Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 6HDM Offers Solution to Health Care Fraud Cited by CNN and Health Plan Week 54205 1HDM Offers Solution to Health Care Fraud Cited by CNN and Health Plan Week 54205 2Plasma Protein Therapeutics Association Urges CMS For Appropriate Hospital Outpatient Drug Reimbursement 54200 1Plasma Protein Therapeutics Association Urges CMS For Appropriate Hospital Outpatient Drug Reimbursement 54200 2Plasma Protein Therapeutics Association Urges CMS For Appropriate Hospital Outpatient Drug Reimbursement 54200 3